FIELD: organic chemistry, pharmacy.
SUBSTANCE: invention relates to new substituted derivatives of pyrrole of the formula (I): wherein R1 and R1' mean independently hydrogen atom (H) or (lower)-alkyl, unsubstituted or substituted (lower)-alkoxy-group; R2 means hydrogen atom (H), nitro-group (-NO2), cyano-group (-CN), halogen atom, unsubstituted (lower)-alkyl or substituted with halogen atom or (lower)-alkoxy-group; R2' means thiazolyl, thiophenyl, isothiazolyl, furanyl and pyrazolyl that is unsubstituted or substituted with (lower)-alkyl, pyrimidinyl, unsubstituted morpholinyl, unsubstituted pyrrolidinyl and imidazolyl that is unsubstituted or substituted with (lower)-alkyl, unsubstituted piperidinyl or piperazinyl that is unsubstituted or substituted with (lower)-alkyl, or ethoxy-group substituted with imidazolyl, or its pharmaceutically acceptable salt. Compounds of the formula (I) inhibit cell proliferation in G2/M phase of mitosis that allows their using in the pharmaceutical composition.
EFFECT: valuable biological properties of compounds.
36 cl, 4 sch, 1 tbl, 21 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED MALEIC ACID BIS-INDOLYLIMIDES FOR INHIBITION OF CELLULAR PROLIFERATION | 2000 |
|
RU2264398C2 |
SUBSTITUTED PYRROLS | 1994 |
|
RU2141960C1 |
DERIVATIVE OF α-AMINOHYDROXAMIC ACID, METHOD FOR ITS PREPARING AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2265592C2 |
SUBSTITUTED BIS-INDOLIMALEIMIDES DESIGNATED FOR INHIBITION OF CELL PROLIFERATION | 1999 |
|
RU2208612C2 |
NEW DERIVATIVES OF HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR MODULATION OF AUTOIMMUNE DISEASES, METHOD FOR PREPARING THESE COMPOUNDS | 2000 |
|
RU2255937C2 |
AMINOPYRAZOLE DERIVATIVE | 2010 |
|
RU2580543C9 |
N-PHENYL-2-PYRIMIDINE DERIVATIVES | 2003 |
|
RU2370493C2 |
METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS | 2012 |
|
RU2665021C2 |
PHENYLETHENYL- OR PHENYLETHYNYL-DERIVATIVES AS ANTAGONISTS OF GLUTAMATE RECEPTORS | 2001 |
|
RU2284323C9 |
HETEROCYCLIC NITROGEN PYRROLE DERIVATIVES, PRODUCING THEM AND PHARMACEUTICAL APPLICATION | 2008 |
|
RU2473543C2 |
Authors
Dates
2005-10-10—Published
2000-12-21—Filed